World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
30318
World Ranking
13569
National Ranking
6900

Overview

Daniel J. Lovell is affiliated with Cincinnati Children's Hospital Medical Center in the United States and has contributed extensively to research in medicine and health professions. Their work predominantly focuses on autoimmune and inflammatory disorders, adolescent and pediatric healthcare, and related fields.

Their main fields of study include:

  • Medicine
  • Health Professions

Within these areas, significant subfields of study covered by their research are:

  • Hematology
  • Speech and Hearing
  • Rheumatology
  • Surgery
  • Public Health, Environmental and Occupational Health

Major research topics addressed by Lovell comprise:

  • Autoimmune and Inflammatory Disorders Research
  • Adolescent and Pediatric Healthcare
  • Kawasaki Disease and Coronary Complications
  • Acute Lymphoblastic Leukemia research
  • Inflammasome and immune disorders
  • Rheumatoid Arthritis Research and Therapies
  • Immunodeficiency and Autoimmune Disorders

Their frequent co-authors demonstrate collaboration with experts in related fields, including:

  • Hermine I. Brunner
  • Nicolino Ruperto
  • Alberto Martini
  • Ivan Foeldvari
  • Е.I. Alexeeva

Lovell has published numerous papers in several well-known academic venues. The most common publication outlets are:

  • Arthritis Care & Research
  • Annals of the Rheumatic Diseases
  • Arthritis & Rheumatology
  • Lara D. Veeken
  • Pediatric Rheumatology

Among recent papers, some noteworthy contributions include:

  • Juvenile idiopathic arthritis (2022) published in Nature Reviews Disease Primers
  • 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis (2022) published in Arthritis & Rheumatology
  • Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial (2020) published in Annals of the Rheumatic Diseases
  • 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis (2022) published in Arthritis Care & Research
  • De novoCIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): A new member of the expanding family of pyrin-associated autoinflammatory diseases (2020) published in UNC Libraries

Best Publications

  • Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

    Daniel J. Lovell;Edward H. Giannini;Andreas Reiff;Gail D. Cawkwell

  • Preliminary definition of improvement in juvenile arthritis

    Edward H. Giannini;Nicolino Ruperto;Angelo Ravelli;Daniel J. Lovell

  • Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

    Marc C. Hochberg;Mark J. Prashker;Maria Greenwald;Rancho Mirage

  • 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features

    Timothy Beukelman;Nivedita M. Patkar;Kenneth G. Saag;Sue Tolleson-Rinehart

  • De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

    Ivona Aksentijevich;Miroslawa Nowak;Mustapha Mallah;Jae Jin Chae

  • Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

    Fabrizio De Benedetti;Hermine I. Brunner;Nicolino Ruperto;Andrew Kenwright

  • Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

    Nicolino Ruperto;Hermine I. Brunner;Pierre Quartier;Tamás Constantin

  • Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

    Daniel J. Lovell;Nicolino Ruperto;Steven Goodman;Andreas Reiff

  • 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: A European league against Rheumatism/American college of Rheumatology/Paediatric rheumatology international trials organisation collaborative initiative

    Angelo Ravelli;Francesca Serena Minoia;Sergio Davi;Anna Carin Horne

  • Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

    Nicolino Ruperto;Daniel J Lovell;Pierre Quartier;Eliana Paz

  • A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

    Nicolino Ruperto;Daniel J. Lovell;Ruben Cuttica;Nick Wilkinson

  • 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis

    Sarah Ringold;Sheila T. Angeles-Han;Timothy Beukelman;Daniel Lovell

  • Toward New Classification Criteria for Juvenile Idiopathic Arthritis : First Steps, Pediatric Rheumatology International Trials Organization International Consensus

    Alberto Martini;Angelo Ravelli;Tadej Avcin;Michael W. Beresford

  • Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

    Daniel J. Lovell;Andreas Reiff;Andreas Reiff;Norman T. Ilowite;Carol A. Wallace

  • 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

    Angelo Ravelli;Francesca Minoia;Sergio Davì;Annacarin Horne

  • 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications

    Sarah Ringold;Pamela F. Weiss;Timothy Beukelman;Esi Morgan DeWitt

  • A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients.

    A M Prieur;C Griscelli;F Lampert;H Truckenbrodt

  • Trial of Early Aggressive Therapy in Polyarticular Juvenile Idiopathic Arthritis

    Carol A. Wallace;Edward H. Giannini;Steven J. Spalding;Philip J. Hashkes;Philip J. Hashkes

  • International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.

    D. A. Isenberg;E. Allen;V. Farewell;M. R. Ehrenstein

  • Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.

    Daniel J. Lovell;Edward H. Giannini;Andreas Reiff;Olcay Y. Jones

Frequent Co-Authors

Nicolino Ruperto
Nicolino Ruperto Istituto Giannina Gaslini
Edward H. Giannini
Edward H. Giannini Cincinnati Children's Hospital Medical Center
Alberto Martini
Alberto Martini University of Genoa
Fabrizio De Benedetti
Fabrizio De Benedetti Bambino Gesù Children's Hospital
Angelo Ravelli
Angelo Ravelli University of Genoa
Nico M Wulffraat
Nico M Wulffraat Utrecht University
John F. Bohnsack
John F. Bohnsack University of Utah
Angela Pistorio
Angela Pistorio Istituto Giannina Gaslini
Scott W. Powers
Scott W. Powers Cincinnati Children's Hospital Medical Center
Peter A. Nigrovic
Peter A. Nigrovic Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking flexible education options, the rise of accredited online programs offers accessible career pathways in healthcare. Nursing school online allows you to balance studies with other responsibilities and still gain core clinical skills.

If you're a registered nurse aiming to advance your credentials, consider the cheapest online BSN programs to move toward leadership roles. For those interested in advanced practice or teaching, the cheapest online DNP programs provide a cost-effective route to doctoral-level study without the need to relocate or pause your career.

Non-nurses wishing to shift into the field can benefit from the cheapest direct entry MSN programs, which fast-track entry into nursing for graduates from other disciplines. These online pathways expand opportunities in healthcare, letting you tailor your learning journey to your professional goals and financial needs.

Best Scientists Citing Daniel J. Lovell

Trending Scientists

Recently Published Articles